(Q46890429)

26 December 2017

title

Recent developments in adaptive designs for Phase I/II dose-finding studies (English)

1 reference

26 December 2017

author

Sylvie Chevret

series ordinal

2

1 reference

26 December 2017

author name string

Sarah Zohar

series ordinal

1

1 reference

26 December 2017

publication date

1 January 2007

1 reference

26 December 2017

Journal of Biopharmaceutical Statistics

published in

1 reference

26 December 2017

volume

17

1 reference

26 December 2017

issue

6

1 reference

26 December 2017

page(s)

1071-1083

1 reference

26 December 2017

A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trial

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10543400701645116

A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400701645116

A Bayesian dose finding design for dual endpoint phase I trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400701645116

Continual reassessment method: a practical design for phase 1 clinical trials in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400701645116

A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400701645116

Dose-finding based on efficacy-toxicity trade-offs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400701645116

Adaptive dose selection using efficacy-toxicity trade-offs: illustrations and practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400701645116

Bayesian decision procedures for dose-escalation based on evidence of undesirable events and therapeutic benefit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400701645116

Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400701645116

Bayesian decision procedures for binary and continuous bivariate dose-escalation studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400701645116

Identifying the most successful dose (MSD) in dose-finding studies in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400701645116

10.1080/10543400701645116

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017